In 1993 Janssen pharmaceuticals, a subset of Johnson & Johnson, received the Food & Drug Administration’s approval of Risperdal. The drug was approved to treat schizophrenia and would restore the balance of dopamine and serotonin regulating moods and other symptoms of schizophrenia.
Although the drug was initially approved for schizophrenia it was also used to treat bipolar disorder, irritability associated with autism, dementia and Tourette’s syndrome.
In 1999 the Food & Drug Administration (FDA) announced their first warning about the drug’s side effects. Although the drug was known to cause muscle weakness, headaches, arrhythmia, and other side effects, by 2005 it was found that some of these side effects could lead to death.
If you or a loved one took Risperdal and experienced adverse medical conditions, the victim may be entitled to compensation for medical bills, lost wages, and more. Our dangerous drug attorneys can help you determine if you may be eligible to file a Risperdal lawsuit.
Fill out the contact form for a no-cost, no-obligation review of your Risperdal claim.
Side Effects of Risperdal
In 2005 the FDA issued an alert in regards to the labeling of Risperdal. The FDA requested that the package insert for Risperdal now include a “black box” warning. A black box warning is the strongest warning the FDA requested and signifies that there is a significant risk of serious or life-threatening side effects.
Some of the adverse medical conditions Risperdal can cause including:
- Neuroleptic malignant syndrome – causes muscles rigidity
- Tardive dyskinesia – results in involuntary movement of the limbs and facial muscles
- Pituitary gland tumors
In patients over the age of 65 suffering from dementia and taking Risperdal, the risk of a stroke was elevated. In April 2003, Johnson & Johnson sent warning letters to physicians across the United States stating such information. More than 15 deaths had been linked to Risperdal.
Additionally, young boys taking Risperdal were at an increased risk of suffering from gynecomastia, male breast development. The association between gynecomastia and Risperdal was first published in Psychopharmacology journal in which a study linked use of the drug along with popular anti-depressant Prozac to the condition. An additional study published in 2006 in the Journal of Clinical Psychopharmacology found that risperidone (the generic form of Risperdal) can strongly increase prolactin levels leading to breast development in young men. The elevated prolactin levels associated with the drug actually persisted for up to years.
Signs of this condition include:
- Breast tenderness
- Nipple discharge
In 2012, the Risperdal manufacturers were fined $1.2 billion for more than 240,000 violations of the Arkansas Medicaid fraud law. Months later the company also settled dozens of lawsuits from victims who suffered gynecomastia due to Risperdal.
Contact our Risperdal Lawyers Today
As the “black box” was not put into place until 2005 for Risperdal, many of those who took the drug suffered from serious side effects and family members lost loved ones due to a manufacturer’s negligence. If you or a loved one has fallen ill or experienced adverse medical side effects caused by Risperdal, we can help.
At The Tapella & Eberspacher Law Firm, our lawyers are experienced in handling dangerous drug litigation and can provide comprehensive legal counsel on your specific claim.
We have offices located in Illinois and are also pleased to help injury victims in St. Louis, Missouri. Contact us at (217) 394-5885 to determine what your legal rights are and if you may be eligible to file a Risperdal lawsuit.